Clinical trial
Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
NCT01227993 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy
- Lead sponsor
- National Eye Institute (NEI)
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- June 30, 2013
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
retinal disease